首页> 美国卫生研究院文献>Asian Pacific Journal of Cancer Prevention : APJCP >Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects

【2h】

Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects

机译：肝细胞癌细胞的索拉非尼-牛磺酸组合模型：免疫学方面

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Sorafenib (Sor) is a multi-kinase inhibitor. It is recommended for the treatment of advanced hepatocellular carcinoma (HCC). However, Sor has severe and marked side effects. On the other hand, taurine (Tau) has been shown to enhance the therapeutic effects of cancer chemotherapy and also to enhance the function of leukocytes.

机译：索拉非尼（Sor）是一种多激酶抑制剂。建议用于治疗晚期肝细胞癌（HCC）。但是，Sor具有严重且明显的副作用。另一方面，牛磺酸（Tau）已显示出增强癌症化学疗法的治疗效果并且还增强白细胞的功能。

著录项

期刊名称 Asian Pacific Journal of Cancer Prevention : APJCP
作者
Ahmed M Afifi; Ahmed M El-Husseiny; Reda H Tabashy; Mohamed A Khalil; Motawa E El-Houseini;
展开▼
作者单位

展开▼
年(卷),期 2019(20),10
年度 2019
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词
HCC; Sorafenib; Taurine; FOXP3; cytokines;

机译：肝癌;索拉非尼;牛磺酸;FOXP3;细胞因子;

相似文献

外文文献
中文文献
专利

1. Sorafenib- or 90Y-loaded resin microsphere radioembolization for locally advanced hepatocellular carcinoma, what should we trust? [J] . Garin Etienne, Rolland Yan, Edeline Julien Liver international : . 2015 ,第6期

机译：索拉非尼或90Y负荷的树脂微球放射性栓塞治疗局部晚期肝细胞癌，我们应该信任什么？
2. Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line RLN-10 in combination with 2-deoxy-D-glucose. [J] . Takemura A, Che XF, Tabuchi T, Oncology reports . 2012 ,第2期

机译：2-氨基苯恶嗪-3-酮对大鼠肝癌细胞系dRLh-84，人肝癌细胞系HepG2和大鼠正常肝细胞系RLN-10联合2的细胞毒性和促凋亡作用的增强脱氧-D-葡萄糖。
3. Dendritic Cells Pulsed with Exosomes in Combination with PD-1 Antibody Increase the Efficacy of Sorafenib in Hepatocellular Carcinoma Model [J] . Shengbin Shi, Quan Rao, Chuangnian Zhang, Translational Oncology . 2018 ,第2期

机译：外来体与PD-1抗体组合刺激树突状细胞增加索拉非尼在肝细胞癌模型中的功效
4. Multi-functional micelles for the combination of chemotherapy and radiotherapy in hepatocellular carcinoma [C] . Ying-Hsia Shih, Cheng-Lian Peng, Tsai-Yueh Luo, Annual NSTI nanotechnology conference and expo . 2013

机译：肝细胞癌化学疗法与放射疗法相结合的多功能胶束
5. Therapeutic Effect of Adenovirus- and alpha-fetoprotein Promoter-mediated tBid and Chemotherapeutic Agents in Combination on Orthotopic Hepatocellular Carcinoma in Mice. [D] . Ma, Shihong. 2010

机译：腺病毒和甲胎蛋白启动子介导的tBid和化学治疗剂联合治疗对小鼠原位肝细胞癌的治疗作用。
6. Dendritic Cells Pulsed with Exosomes in Combination with PD-1 Antibody Increase the Efficacy of Sorafenib in Hepatocellular Carcinoma Model [O] . Shengbin Shi, Quan Rao, Chuangnian Zhang, 2018

机译：外来体与PD-1抗体组合刺激树突状细胞增加索拉非尼在肝细胞癌模型中的功效
7. Enhancement of cytotoxic and pro-apoptotic effects of 2-aminophenoxazine-3-one on the rat hepatocellular carcinoma cell line dRLh-84, the human hepatocellular carcinoma cell line HepG2, and the rat normal hepatocellular cell line RLN-10 in combination with 2-deoxy-D-glucose [O] . Akio Tomoda 2011

机译：增强2-氨基苯并嗪-3-1对大鼠肝细胞癌细胞系DrlH-84，人肝细胞癌细胞系HepG2和大鼠常肝细胞系R1N-10的细胞毒性和促凋亡作用脱氧-D-葡萄糖

Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects

摘要

著录项

相似文献

相关主题

期刊订阅